CAI vs RDNT: stock comparison and AI forecast
Caris Life Sciences, Inc. (CAI) and Radnet, Inc. (RDNT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CAI Caris Life Sciences, Inc.
- Price
- $34.33 +80.7% · 6M
- Market Cap
- $9.70B
- P/E Ratio
- 7.2x
- Size
- mid-cap
- AI Forecast
- NO CURRENT FORECAST
RDNT Radnet, Inc.
- Price
- $73.49 +30.0% · 6M
- Market Cap
- $5.78B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
- NO CURRENT FORECAST
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- CAI is 1.7 times larger than RDNT by market capitalization ($9.70B against $5.78B).
- Over the last six months CAI returned +80.7% and RDNT +30.0%.
- RDNT carries 2.58 times debt per unit of equity, against 1.08 times for CAI.
- Both companies share the SEC industry classification Services-Medical Laboratories.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CAI | RDNT |
|---|---|---|
| Market Cap | $9.70B | $5.78B |
| P/E Ratio | 7.23x | – |
| P/B Ratio | 16.40x | 5.28x |
| EPS | $4.75 | $-0.34 |
| Book Value/Share | $2.09 | $13.93 |
| Revenue/Share | $3.93 | $28.83 |
| FCF/Share | $0.44 | – |
Profitability & Margins
| Metric | CAI | RDNT |
|---|---|---|
| ROE | – | -1.9% |
| ROA | – | -0.5% |
| ROIC | 9.2% | 2.0% |
| Operating Margin | 8.6% | 3.1% |
| Net Margin | – | -0.9% |
| EBT Margin | 0.2% | 1.5% |
| Tax Rate | -4.5% | 44.9% |
Financial Health
| Metric | CAI | RDNT |
|---|---|---|
| Current Ratio | 5.53x | 1.48x |
| D/E Ratio | 1.08x | 2.58x |
| Financial Leverage | 2.08x | 3.86x |
| Interest Coverage | 2.9x | 2.2x |
| Working Capital | $866M | $338M |
Cash Flow
| Metric | CAI | RDNT |
|---|---|---|
| Operating Cash Flow | $169M | $310M |
| Free Cash Flow | $124M | – |
| Capital Spending | -$45M | – |
| OCF Growth YoY | – | 18.4% |
| FCF/Sales | 11.2% | – |
| CapEx/Sales | 4.0% | – |
Operational Efficiency
| Metric | CAI | RDNT |
|---|---|---|
| Asset Turnover | 0.90x | 0.54x |
| Receivables Turnover | 9.5x | 9.4x |
| Fixed Assets Turnover | 11.6x | 2.6x |
| Days Sales Outstanding | 38 days | 39 days |
Income Statement
| Metric | CAI | RDNT |
|---|---|---|
| Total Revenue | $1.11B | $2.27B |
| Operating Income | $95M | $71M |
| Net Income | – | -$21M |
| R&D Expense | $140M | – |
| SG&A Expense | $672M | – |
Dividend & Shareholder Information
| Metric | CAI | RDNT |
|---|---|---|
| Shares Outstanding | 283M | 79M |
| EPS Growth | – | -225.9% |
CAI vs RDNT: stock comparison and AI forecast
Which is bigger, CAI or RDNT?
CAI is 1.7 times larger than RDNT by market capitalization ($9.70B against $5.78B).
Which stock performed better over the last six months, CAI or RDNT?
Over the last six months CAI returned +80.7% and RDNT +30.0%.
Which one does Intratio's AI model rank higher, CAI or RDNT?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.